In AMC‐HN8 cells, CKS2, as a direct target of miR‐26a, induced cell migration and invasion, suggesting that CKS2 could be a novel therapeutic target for laryngeal squamous cell carcinoma (LSCC).12 The gene discussed is CKS2; the disease is laryngeal squamous cell carcinoma.